VION PHARMACEUTICALS INC·4

Oct 18, 7:47 PM ET

Cahill Ann Lee 4

4 · VION PHARMACEUTICALS INC · Filed Oct 18, 2004

Insider Transaction Report

Form 4
Period: 2004-10-15
Cahill Ann Lee
V.P., Clinical Development
Transactions
  • Award

    Option to purchase

    2004-10-15+55,00055,000 total
    Exercise: $4.31Exp: 2014-10-15Common Stock (55,000 underlying)
Footnotes (2)
  • [F1]The option agreement provides that the option shall generally become exercisable with respect to 25% of the shares subject thereto as of each of October 15, 2005, October 15, 2006, October 15, 2007 and October 15, 2008.
  • [F2]Grant of derivative security.

Documents

1 file
  • 4
    edgar123.xmlPrimary

    FORM 4